BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2635137)

  • 21. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
    Serclová L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(5):649-55. PubMed ID: 3155391
    [No Abstract]   [Full Text] [Related]  

  • 23. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
    Weisshaar E; Dunker N; Röhl FW; Gollnick H
    Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of thioridazine and diazepam in non-psychotic anxiety-depression: a pilot study.
    Schuster TS; Winslow WW; Kellner R
    Curr Ther Res Clin Exp; 1972 Mar; 14(3):131-5. PubMed ID: 4622892
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of peripheral vascular diseases with dihydroergocristine].
    Moracchini PV; Alfano G; Melandri F
    Minerva Cardioangiol; 1978 Apr; 26(4):277-90. PubMed ID: 97601
    [No Abstract]   [Full Text] [Related]  

  • 27. Dementia: differential diagnosis and treatment.
    Yesavage J
    Geriatrics; 1979 Sep; 34(9):51-9. PubMed ID: 38188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
    Yesavage JA; Hollister LE; Burian E
    J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effect and plasma level of thioridazine.
    de Jonghe FE; van der Helm HJ; Schalken HF; Thiel JH
    Acta Psychiatr Scand; 1973; 49(5):535-45. PubMed ID: 4586599
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the effectiveness and tolerance of dihydroergotoxine and alpha methyldopa in the therapy of arterial hypertension in the elderly with senile cerebral insufficiency].
    Bergamasco B; Scarzella L; Turri D
    Recenti Prog Med; 1987 Apr; 78(4):166-70. PubMed ID: 3628936
    [No Abstract]   [Full Text] [Related]  

  • 31. Relief of mixed anxiety-depression in terminal cancer patients. Effect of thioridazine.
    Johnston B
    N Y State J Med; 1972 Sep; 72(18):2315-7. PubMed ID: 4560963
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Kristepin and obzidan treatment of patients with hypertension].
    Leviashvili BI
    Vrach Delo; 1989 Jun; (6):39-40. PubMed ID: 2506697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience in the treatment of increased blood pressure with a combination of dihydroergotoxine, reserpine and hydrochlorothiazide].
    Prcović M; Stanković M
    Med Pregl; 1984; 37(3-4):131-5. PubMed ID: 6493145
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
    Milvio C
    Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thioridazine as an antidepressant.
    Practitioner; 1972 Jul; 209(249):95-8. PubMed ID: 4557482
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
    Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV
    Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of vasobral in therapy of central nervous system pathology in children of early age].
    Zaĭtseva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment by sandoven-f in patients with venous affections (author's transl)].
    Viviani E
    Schweiz Rundsch Med Prax; 1975 Oct; 64(41):1320-3. PubMed ID: 815900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.